HA-Drug-Conjugates, HA conjugates CNS, wAMD, PDAC, TNBC, Alzheimer's, RNA delivery, Oral wAMD, IBD, estrogen, cognitive,
Holy Stone Healthcare Co., Ltd. is a platform-driven biotechnology company dedicated to developing precision-targeted hyaluronic acid (HA) conjugates. Specializing in CNS, oncology, mucosal, and ocular delivery, Holy Stone Healthcare's proprietary Hyaluronic Acid Drug Delivery (HylX ) platform enables site-selective, CD44-mediated uptake of poorly soluble or systemic-exposure–sensitive payloads.
Holy Stone Healthcare Co., Ltd. offers a modular platform family, including HyaNeuro™ for CNS-targeted BBB penetration delivery for neurodegeneration, HyaTargis™ for solid tumor-selective delivery of small-molecule inhibitors, HyaRetinX™ for oral BRB penetration HA-conjugate for retinal neovascular diseases, HyaMusa™ for mucosal targeting for mucosal healing and anti-inflammation, and HyaCaryo™ a HA nanoparticle system for RNA/nucleic acid delivery. Holy Stone Healthcare is located at 4F, No. 88, Sec. 1, Neihu Rd., Neihu Dist., Taipei, 11493, TW and 2F, No. 26, Sec. 2, ShengYi Rd., Zhubei City, Hsinchu County 30261, TW; Henderson Business Centre, Unit 32/33, Ivy Road Norwich, Norfolk, NR5 8BF, GB; and Rue du 31 Décembre, 36, 1207 Geneva, 1207, CH.
With a strong focus on innovation and precision, Holy Stone Healthcare Co., Ltd. is poised to make significant advancements in the field of targeted drug delivery. The company continues to expand its capabilities and explore new applications for its HylX platform, further solidifying its position as a leader in the biotechnology industry. We invite the manager of Holy Stone Healthcare Co., Ltd. to create a customized and exclusive company showcase and product listing on our platform.
Compare Holy Stone Healthcare Co., Ltd. with 3 companies in Pharmaceutical-Manufacturing
| Comparison Field |
Holy Stone Healthcare Co....Main Company |
CK Birla HospitalView Profile |
Ann & Robert H. Luri...View Profile |
Zydus HospitalsView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 0 | 2015 | |
|
Company Size
|
— | 501-1,000 | 1,001-5,000 | 1,001-5,000 |
|
City
|
Gurgaon, Haryana | Chicago, IL | Ahmedabad, Gujarat | |
|
Country
|
India | United States | India | |
|
Skills & Keywords
Comparing with main company
|
22 Total Skills
Hyaluronic Acid Conjugates
Drug Delivery Systems
CNS Delivery
Oncology Therapeutics
Mucosal Delivery
Ocular Delivery
Biotechnology
CD44-mediated endocytosis
modified HA
HA-Based Inorganic Conjugate Composites
Combination of HA & Other Biopolymer Crosslinked Systems
Autoimmune Disease
Drug Delivery
enhanced permeability & retention effect
CD44v
HA Derivatives as Cell-Based Therapeutics
Oncology
CD44
HA as a Biocoating Polymer & Its Therapy
HA polymer chains synthesis
Hyaluronic Acid-Based Bioconjugate
Gastroenterology
|
18 Total
18 Unique
Unique Skills:
Advanced Surgical Sciences
Cardiology
Critical Care & Anaesthesia
Diagnostics
Dietetics
Endocrinology
+12
|
14 Total
14 Unique
Unique Skills:
Allergy & Immunology
Brain Tumors
Cardiology & Heart Surgery
Emergency Medicine
Fetal Conditions
Kidney Disease
+8
|
20 Total
20 Unique
Unique Skills:
Cardiac Surgery
Cardiology
Critical & Intensive Care
Endocrinology
ENT & Choclear Implantation
Hip Joint Replacement Surgery
+14
|
Other organizations in the same industry
This company is also known as